Stock Research: Surmodics

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Surmodics

NasdaqGS:SRDX US8688731004
9
  • Value
    63
  • Growth
    5
  • Safety
    Safety
    50
  • Combined
    18
  • Sentiment
    14
  • 360° View
    360° View
    9
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Surmodics, Inc. provides performance coating technologies for medical devices and chemical/biological components for in vitro diagnostic tests, also developing vascular intervention medical devices. It operates in the Medical Device and IVD segments, serving neurovascular, peripheral, coronary, diagnostic, and biomedical research markets. In the last fiscal year, the company had a market cap of $451 million, profits of $93 million, revenue of $126 million, and 389 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 9 (better than 9% compared with alternatives), overall professional sentiment and financial characteristics for the stock Surmodics are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Surmodics. The consolidated Value Rank has an attractive rank of 50, which means that the share price of Surmodics is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 50% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 63. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 14. Professional investors are more confident in 86% other stocks. The consolidated Growth Rank also has a low rank of 5, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 95 of its competitors have better growth. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
50 45 28 13
Growth
5 83 53 3
Safety
Safety
63 73 37 82
Sentiment
14 16 67 34
360° View
360° View
9 59 33 10
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
1 7 97 96
Opinions Change
50 92 50 50
Pro Holdings
n/a 4 52 6
Market Pulse
67 50 23 25
Sentiment
14 16 67 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
50 45 28 13
Growth
5 83 53 3
Safety Safety
63 73 37 82
Combined
18 93 17 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
38 38 15 15
Price vs. Earnings (P/E)
48 45 40 40
Price vs. Book (P/B)
54 51 42 36
Dividend Yield
1 1 1 1
Value
50 45 28 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
14 39 84 9
Profit Growth
38 96 4 1
Capital Growth
13 75 62 11
Stock Returns
25 57 63 63
Growth
5 83 53 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
70 70 60 73
Refinancing
49 49 27 19
Liquidity
35 47 50 89
Safety Safety
63 73 37 82

Similar Stocks

Discover high‑ranked alternatives to Surmodics and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.